Document is current

Article History

Accepted: 14 April 2021

First Online: 14 June 2021

Declarations

:

: Dr. John A. Spertus discloses grant funding from NIH and Abbott Vascular. He serves on a Scientific Advisory Board for United Healthcare and is a board member for Blue Cross Blue Shield of Kansas City. He is also a consultant for Novartis, Bayer, AstraZeneca, Janssen, Merck, Myokardia, Amgen, and Bayer. He has intellectual property rights for the Kansas City Cardiomyopathy Questionnaire, Seattle Angina Questionnaire, and Peripheral Artery Questionnaire and an equity interest in Health Outcomes Sciences.The other authors have no conflicts of interest.

: This article does not contain any studies with human or animal subjects performed by any of the authors.